This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergström, S
Right arrow Articles by Normark, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergström, S
Right arrow Articles by Normark, S

Next Article 

Antimicrob Agents Chemother. 1979 October; 16(4): 427-433

Beta-lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal beta-lactamase.

S Bergström and S Normark

ABSTRACT

Among cephalothin-resistant isolates from patients with urinary tract infections, six Escherichia coli strains were found to produce elevated amounts of a beta-lactamase indistinguishable from that coded by the ampC gene of E. coli K-12. The resistance levels displayed by these isolates toward a number of beta-lactams were, for five of them, considerably higher as compared with E. coli K-12 with the same amount of beta-lactamase, implying the importance of intrinsic resistance in these isolates. Cefuroxime, and to a lesser extent cefamandole, were stable to hydrolysis by E. coli chromosomal beta-lactamase but acted as inhibitors of the enzyme. Nevertheless, increased beta-lactamase production mediated an increased resistance toward these drugs. No plasmids were found in the isolates, suggesting a chromosomal location for the respective ampC locus.


Antimicrob Agents Chemother. 1979 October; 16(4): 427-433




This article has been cited by other articles:

  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Spoering, A. L., Vulic, M., Lewis, K. (2006). GlpD and PlsB Participate in Persister Cell Formation in Escherichia coli.. J. Bacteriol. 188: 5136-5144 [Abstract] [Full Text]  
  • Siu, L. K., Lu, P.-L., Chen, J.-Y., Lin, F. M., Chang, S.-C. (2003). High-Level Expression of AmpC {beta}-Lactamase Due to Insertion of Nucleotides between -10 and -35 Promoter Sequences in Escherichia coli Clinical Isolates: Cases Not Responsive to Extended-Spectrum-Cephalosporin Treatment. Antimicrob. Agents Chemother. 47: 2138-2144 [Abstract] [Full Text]  
  • Viveiros, M., Portugal, I., Bettencourt, R., Victor, T. C., Jordaan, A. M., Leandro, C., Ordway, D., Amaral, L. (2002). Isoniazid-Induced Transient High-Level Resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46: 2804-2810 [Abstract] [Full Text]  
  • Wu, S. W., Dornbusch, K., Kronvall, G., Norgren, M. (1999). Characterization and Nucleotide Sequence of a Klebsiella oxytoca Cryptic Plasmid Encoding a CMY-Type beta -Lactamase: Confirmation that the Plasmid-Mediated Cephamycinase Originated from the Citrobacter freundii AmpC beta -Lactamase. Antimicrob. Agents Chemother. 43: 1350-1357 [Abstract] [Full Text]  
  • Nelson, E. C., Elisha, B. G. (1999). Molecular Basis of AmpC Hyperproduction in Clinical Isolates of Escherichia coli. Antimicrob. Agents Chemother. 43: 957-959 [Abstract] [Full Text]  
  • Chaibi, E. B., Sirot, D., Paul, G., Labia, R. (1999). Inhibitor-resistant TEM {beta}-lactamases: phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother 43: 447-458 [Abstract] [Full Text]  
  • Speldooren, V., Heym, B., Labia, R., Nicolas-Chanoine, M.-H. (1998). Discriminatory Detection of Inhibitor-Resistant beta -Lactamases in Escherichia coli by Single-Strand Conformation Polymorphism-PCR. Antimicrob. Agents Chemother. 42: 879-884 [Abstract] [Full Text]